The BIOCREDIT COVID-19 Ag Home Test met the selection criteria and was forwarded for full evaluation by Science and Technical Advisory.

Upon full evaluation, the BIOCREDIT COVID-19 Ag Home Test was recommended for import, supply and/or use in Aotearoa New Zealand. This recommendation was then approved and authorization was given by the Director-General of Health on 15 March 2022. 

 
We appreciate your patience and continued interest in supporting Rapigen.